New Age Alpha Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.23 Trillion
- Q1 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 1,403 shares of REGN stock, worth $789,889. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,403
Previous 8,312
83.12%
Holding current value
$789,889
Previous $5.92 Billion
84.97%
% of portfolio
0.04%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,417Shares Held
85MCall Options Held
1.39MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.3 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.7 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.25 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...